Jeil Pharma Holdings Inc

KOSE:A002620 Stock Report

Market Cap: ₩162.1b

Jeil Pharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A002620?
Owner TypeNumber of SharesOwnership Percentage
Institutions8,2810.0539%
Public Companies1,497,0509.75%
General Public2,159,31114.1%
Individual Insiders11,686,48376.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 85.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
66%
Seung-Soo Han
10,137,181₩107.0b0%no data
10.1%
Sangchul Han
1,549,302₩16.4b0%no data
9.75%
Otsuka Holdings Co., Ltd.
1,497,050₩15.8b0%no data
0.026%
Samsung Asset Management Company, Ltd.
4,045₩42.7m7.61%no data
0.014%
Hanwha Asset Management Co. Ltd.
2,122₩22.4m0%no data
0.0074%
Mirae Asset Global Investments Co., Ltd.
1,135₩12.0m-33%no data
0.006%
KB Asset Management Co., Ltd.
924₩9.8m-56%no data
0.00036%
Korea Investment Management Co., Ltd.
55₩583.6k-28.6%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.